Editorial policy
Editorial policy
Our public pages are written to be useful, cautious and clear about uncertainty.
Availability claims
We do not present US approval as UK approval, and we do not claim live UK provider access unless that access is supported by current public evidence.
Provider comparisons
Phase-one provider comparison focuses on public information, availability warnings, waitlist signals and route context. It does not rank providers or turn unavailable products into price-led claims.
Medical context
Tablet Compare provides information and comparison only. Clinical questions should be discussed with a qualified healthcare professional.